How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Two Concurrent Outbreaks of Listeria monocytogenes Infections Linked to Packaged Salads, United States, 2014–2022 – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Early Release – Retrospective Multicenter Study of Human Granulocytic Anaplasmosis, France, 2012–2024 – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Early Release – Reduced Emergency Department Visits and Hospitalizations in Infants after Universal Respiratory Syncytial Virus Immunization, Italy, 2024–25 – Volume 32, Number 1—January 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 6-12 December 2025, week 50

Early Release – Novel Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025 – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Early Release – Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024–2025 – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Early Release – Wild and Domestic Animal Exposure among Deceased Persons Referred for Organ Procurement, United States – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Early Release – Human Infection by Zoonotic Eye Fluke Philophthalmus lacrymosus, South America – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Early Release – Case of Congenital Tularemia with Neuroinvasive Disease, Utah, USA – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Early Release – West Nile Virus–Associated Hemophagocytic Lymphohistiocytosis, Switzerland – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us